New purity offering, off-target analysis services and additional solutions help to bridge the gap from discovery research to clinical translation and advance CRISPR-based therapies

IDT launches all-inclusive gene fragments from 7 cents per base with 25% lower turnaround times and next-day shipping powered by its cutting-edge synthetic biology facility

Expanded portfolio offerings include first-to-market product launches to support global health challenges New infectious disease research solutions to be spotlighted at ASM Microbe 2025

The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and speedy speech.

A solar-powered nitrate treatment unit is installed to demonstrate circular resource recovery

White glove manufacturing service aims to enhance design-build-test cycle and drive rapid innovation

Aldevron and Integrated DNA Technologies – both part of the Danaher Corporation – have achieved a medical milestone with the successful manufacture of the world’s first personalized CRISPR gene-editing drug product to treat an infant suffering from a rare and life-threatening genetic condition known as urea cycle disorder (UCD).

Steven Davis, Co-Founder and CEO of Bio::Neos, Inc. —a BioVentures Center tenant—received the Youth Engagement Award.